Summary
Alley Stanley, a mother from Nevada, discovered her son Stone had a rare genetic disorder called Hunter Syndrome, after initially believing he was healthy. Hunter Syndrome is a progressive condition caused by a missing enzyme, leading to a buildup of harmful substances in the body. Although current treatments help manage the condition, they can't fully reach the brain, but a newly approved therapy offers hope.
Key Facts
- The condition, Hunter Syndrome (MPS II), is a rare genetic disorder.
- Symptoms included language delay, fluid behind the eardrums, and a hernia.
- Testing confirmed the diagnosis after initial doubts from doctors.
- Hunter Syndrome causes toxins to build up because of a missing enzyme.
- Existing treatments can manage symptoms but not reach the brain.
- A new therapy that treats the brain has been approved in the U.S.
- Regulatory delays can affect the availability of rare disease treatments.
- The new therapy approval is seen as a major breakthrough for affected families.
